English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/114881
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Benzothiazepine CGP37157 and its isosteric 2′-ethyl analogue provide neuroprotection and block cell calcium entry

AuthorsGonzález-Lafuente, Laura; Egea, Javier; León, Rafael; Martínez-Sanz, F. J.; Monjas, Leticia ; Pérez, Concepción; Merino, Cristina; García-De Diego. Antonio M.; Rodríguez-Franco, María Isabel ; García, Antonio G.; Villarroya, Mercedes; Lopez, Manuela G.; Ríos, Cristóbal de los
KeywordsNeuroprotection
Oxidative stress
Mitochondrial sodium calcium exchanger
CGP37157
Cell calcium
Alzheimer’s disease
Issue Date2012
CitationACS Chemical Neuroscience 3: 519-529 (2012)
AbstractBenzothiazepine CGP37157 is widely used as tool to explore the role of mitochondria in cell Ca 2+ handling, by its blocking effect of the mitochondria Na +/Ca 2+ exchanger. Recently, CGP37157 has shown to exhibit neuroprotective properties. In the trend to improve its neuroprotection profile, we have synthesized ITH12505, an isosteric analogue having a methyl instead of chlorine at C2′ of the phenyl ring. ITH12505 has exerted neuroprotective properties similar to CGP37157 in chromaffin cells and hippocampal slices stressed with veratridine. Also, both compounds afforded neuroprotection in hippocampal slices stressed with glutamate. However, while ITH12505 elicited protection in SH-SY5Y cells stressed with oligomycin A/rotenone, CGP37157 was ineffective. In hippocampal slices subjected to oxygen/glucose deprivation plus reoxygenation, ITH12505 offered protection at 3-30 μM, while CGP37157 only protected at 30 μM. Both compounds caused blockade of Ca 2+ channels in high K +-depolarized SH-SY5Y cells. An in vitro experiment for assaying central nervous system penetration (PAMPA-BBB; parallel artificial membrane permeability assay for blood-brain barrier) revealed that both compounds could cross the blood-brain barrier, thus reaching their biological targets in the central nervous system. In conclusion, by causing a mild isosteric replacement in the benzothiazepine CGP37157, we have obtained ITH12505, with improved neuroprotective properties. These findings may inspire the design and synthesis of new benzothiazepines targeting mitochondrial Na +/Ca 2+ exchanger and L-type voltage-dependent Ca 2+ channels, having antioxidant properties. © 2012 American Chemical Society.
URIhttp://hdl.handle.net/10261/114881
DOI10.1021/cn300009e
Identifiersdoi: 10.1021/cn300009e
issn: 1948-7193
e-issn: 1948-7193
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.